The MYOVIEW Bibliography is comprised of interesting and informative studies and trials that focus on MYOVIEW and other perfusion agents.

Jain D. Technetium-99m labeled myocardial perfusion imaging agents. Semin Nucl Med. 1999;29:221-236.

Zaret BL, Rigo P, Wackers FJ, et al. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201TI imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. Circulation. 1995;91:313-319.

Heller GV, Stowers SA, Hendel RC, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol. 1998;31:1011-1017.

Münch G, Neverve J, Matsunari I, Schroter G, Schwaiger M. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. J Nucl Med. 1997;38:428-432.

Kelly JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med. 1993;34:222-227.

Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-tetrofosmin. I: uptake into isolated adult rat ventricular myocytes and subcellular localization. J Nucl Cardiol. 1995;2:317-326.

Younes A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A. Mechanism of uptake of technetium-tetrofosmin. II: uptake into isolated adult rat heart mitochondria. J Nucl Cardiol. 1995;2:327-333.

Higley B, Smith FW, Gemmell HG, et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino] ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med. 1993;34:30-38.

Jain D, Wackers FJ, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med. 1993;34:1254-1259.

Murray T, Bolster AA, Hilditch TE, Elliot AT. Technetium-99m-tetrofosmin: retention of nitrogen atmosphere in kit vial as a cause of poor quality material. Nucl Med Commun. 2000;21:845-849.

4th International Conference–Nuclear Cardiology Today, 2000 and Beyond; Cesena, Italy. Conference proceedings to be made available separately on CD-ROM.

Thorley PJ, Ball J, Sheard KL, Sivananthan UM. Evaluation of 99Tcm-tetrofosmin as a myocardial perfusion agent in routine clinical use. Nucl Med Commun. 1995;16:733-740.

Montz R, Perez-Castejon MJ, Jurado JA, et al. Technetium-99m tetrofosmin rest/stress myocardial SPET with a same-day 2-hour protocol: comparison with coronary angiography. A Spanish-Portuguese multicentre clinical trial. Eur J Nucl Med. 1996;23:639-647.

van Eck-Smit BL, Poots S, Zwinderman AH, Bruschke AV, Pauwels EK, van der Wall EE. Myocardial SPET imaging with 99Tcm-tetrofosmin in clinical practice: comparison of a 1-day and a 2-day imaging protocol. Nucl Med Commun. 1997;18:24-30.

Thorley PJ, Sheard KL, Wright DJ, Sivananthan UM. The routine use of sublingual GTN with resting 99Tcm-tetrofosmin myocardial perfusion imaging. Nucl Med Commun. 1998;19:937-942.

Cuocolo A, Sullo P, Pace L, et al. Adenosine coronary vasodilation in coronary artery disease: technetium-99m tetrofosmin myocardial tomography versus echocardiography. J Nucl Med. 1997;38:1089-1094.

Thorley PJ, Bloomer TN, Sheard KL, Sivananthan UM. The use of GTN to improve the detection of ischaemic myocardium using 99Tcm-tetrofosmin. Nucl Med Commun. 1996;17:669-674.

Peix A, Lopez A, Ponce F, et al. Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration. J Nucl Cardiol. 1998;5:469-476.

Flotats A, Carrio I, Estorch M, et al. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography. Eur J Nucl Med. 1997;24:767-773.

Galassi AR, Tamburino C, Grassi R, et al. Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction. J Nucl Cardiol. 1998;5:56-63.

Fukuzawa S, Inagaki M, Morooka S, et al. Evaluation of myocardial viability using sequential dual-isotope single photon emission tomography imaging with rest TI-201/ stress Tc-99m tetrofosmin in the prediction of wall motion recovery after revascularization. Jpn Circ J. 1997;61:481-487.

Acampa W, Cuocolo A, Petretta M, et al. Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and T1-201 scintigraphy. J Nucl Cardiol. 2002;9:33-40.

Heo J, Cave V, Wasserleben V, Iskandrian AS. Planar and tomographic imaging with technetium 99m-labeled tetrofosmin: correlation with thallium 201 and coronary angiography. J Nucl Cardiol. 1994;1:317-324.

Mahmood S, Gunning M, Bomanji JB, et al. Combined rest thallium-201/ stress technetium-99m-tetrofosmin SPECT: feasibility and diagnostic accuracy of a 90-minute protocol. J Nucl Med. 1995;36:932-935.

Kumita S, Kumazaki T, Cho K, et al. Rapid data acquisition protocol in ECG-gated myocardial perfusion SPECT with Tc-99m-tetrofosmin. Ann Nucl Med. 1998;12:71-75.

Everaert H, Vanhove C, Franken PR. Gated SPET myocardial perfusion acquisition within 5 minutes using focussing collimators and a three-head gamma camera. Eur J Nucl Med. 1998;25:587-593.

Everaert H, Franken PR, Flamen P, Goris M, Momen A, Bossuyt A. Left ventricular ejection fraction from gated SPET myocardial perfusion studies: a method based on the radial distribution of count rate density across the myocardial wall. Eur J Nucl Med. 1996;23:1628-1633.

Yamagishi H, Akioka K, Hirata K, et al. Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium. J Nucl Cardiol. 2001;8:58-67.

Kumita S, Cho K, Nakajo H, et al. Assessment of left ventricular diastolic function with electrocardiography-gated myocardial perfusion SPECT: comparison with multigated equilibrium radionuclide angiography. J Nucl Cardiol. 2001;8:568-574.

Sharir T, Germano G, Kang X, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med. 2001;42:831-837.

Hirata K, Takamiya M, Kinoshita N, et al. Interpretation of reverse redistribution of 99mTc-tetrofosmin in patients with acute myocardial infarction. Eur J Nucl Med. 2002;29:1594-1599.

Kapur A, Latus K, Davies G, et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study. European Association of Nuclear Medicine–online journal October 2002.

Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation. 2000;101:1465-1478.